Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Aditxt ( (ADTX) ) is now available.
Aditxt, Inc. has been actively working on a merger with Evofem Biosciences, Inc., with the latter becoming a wholly owned subsidiary. The merger agreement has undergone several amendments, with the latest being Amendment No. 6 on August 26, 2025. These amendments have included changes to investment amounts, dates, and shareholder approval definitions, reflecting ongoing negotiations and adjustments in the merger process.
More about Aditxt
Average Trading Volume: 842,954
Technical Sentiment Signal: Strong Sell
Current Market Cap: $5.28M
See more insights into ADTX stock on TipRanks’ Stock Analysis page.